Protodesnitazene is a benzimidazole derivative which has been sold as a designer drug, and has potent opioid effects. It has been identified in Canada, Australia, the United Kingdom and Finland, first appearing in early 2025.
See also Butodesnitazene Etodesnitazene Etomethazene Metodesnitazene Protonitazene List of benzimidazole opioids
References